Business Wire

ISACA

9.9.2022 14:31:43 CEST | Business Wire | Press release

Share
ISACA Expands European Presence With New Office in Dublin

As a result of the continued growth and development over the last 50 years, ISACA, the global professional association advancing individuals and organizations in their pursuit of digital trust, is expanding its international reach and opening a new office in Dublin—its first European office.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220909005075/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Chris Dimitriadis, Chief Global Strategy Officer at ISACA (Photo: Business Wire)

ISACA´s success is defined by the passion, hard work and commitment of its more than 165,000 members in more than 180 countries worldwide. In Europe, the organization has over 30,000 members working in information and cyber security, assurance, governance, risk and privacy from different industries such as Banking & Finance, Government, Telecommunications, Engineering, Public Accounting, Education, Retail, Health, FMCG, Automotive, Utilities, Food & Beverage among others.

ISACA in Europe combines the strength and scale of a large, multi-national organization with an expert, local knowledge of the market and professional communities ISACA serves. The new office intends to facilitate cooperation between European regions, chapters and members and strengthen ISACA’s capacity to collaborate with key public and private stakeholders, as well as enterprises and academia.

“Our expanded regional presence in Europe will provide services dedicated to Europe and help extend our global reach and impact,” said ISACA CEO David Samuelson. “ISACA is both a global and a local organization, and we want to serve our professional communities where they live and work. We are very excited to have a stronger local presence in Europe to better partner with European government, enterprises, universities and our members to advance digital trust.”

The office and ISACA’s new team members in Europe will build on the strong ties that already exist between regions by promoting investment, synergies and economic opportunities to benefit members and enterprises.

Ireland’s Minister of State for eGovernment Ossian Smyth said, “We welcome ISACA’s commitment and investment into Ireland. As we continue to develop Ireland as a European hub for the digital economy and as a cyber centre of excellence, it is crucial to continue to build an expert and diverse specialist ecosystem. ISACA’s pre-eminent global work on talent development, building the cyber profession and developing tools and frameworks to underpin the next phase of technology adoption in a safe and transparent manner, will be a boost to our tech scene. We look forward to ongoing cooperation with ISACA in improving cybersecurity preparedness and resilience.”

ISACA’s European presence is led by Chris Dimitriadis, Chief Global Strategy Officer at ISACA. Dimitriadis has deep industry and ISACA experience, having served as ISACA board chair and as a past chief information security officer at a global organization.

“ISACA has a long history in Europe, and we are incredibly proud of our chapters, volunteers, members and partners in the region,” said Dimitriadis. “We are excited to strengthen our support in the communities that we serve by establishing a team of highly experienced and reputable European professionals and by opening our first office in Dublin that will strategically coordinate and support our 45 chapters in Europe and our business, government and academic partners.”

ISACA, established in 1969, is widely known for its globally recognized certifications, including Certified Information Systems Auditor (CISA) and Certified Information Security Manager (CISM), and its industry-leading frameworks, including COBIT. Additional information is at www.isaca.org/.

About ISACA

ISACA® (www.isaca.org) is a global community advancing individuals and organizations in their pursuit of digital trust. For more than 50 years, ISACA has equipped individuals and enterprises with the knowledge, credentials, education, training and community to progress their careers, transform their organizations, and build a more trusted and ethical digital world. ISACA is a global professional association and learning organization that leverages the expertise of its more than 165,000 members who work in digital trust fields such as information security, governance, assurance, risk, privacy and quality. It has a presence in 188 countries, including 225 chapters worldwide. Through its foundation One In Tech, ISACA supports IT education and career pathways for underresourced and underrepresented populations.

Twitter: www.twitter.com/ISACANews
LinkedIn: www.linkedin.com/company/isaca
Facebook: www.facebook.com/ISACAGlobal
Instagram: www.instagram.com/isacanews

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220909005075/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye